newlink
Merck Ebola vaccine safe and effective in latest trials
April 2, 2015Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink
Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …
Merck and NewLink Ebola vaccine trial begins
March 6, 2015Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
GSK launches Ebola Phase III trial in Liberia
January 23, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink
A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …
Gavi pledges $300 million for Ebola vaccines
December 12, 2014Manufacturing and Production, Sales and Marketing GAVI, GSK, GlaxoSmithKline, J&J, JJ, Merck, Vaccine, WHO, newlink
The global vaccines alliance Gavi has committed to buying Ebola vaccines as soon as the World Health Organization recommends one …
